Filing Details

Accession Number:
0001062993-21-003445
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-06 15:52:44
Reporting Period:
2021-03-30
Accepted Time:
2021-04-06 15:52:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098880 Intelgenx Technologies Corp. IGXT Pharmaceutical Preparations (2834) 870638336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381861 Bernard Boudreau 74 Brearmount Drive
Halifax A5 B3M 2P2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, 0.00001 P.v. Acquisiton 2021-03-30 12,500 $0.40 135,500 No 4 P Direct
Common Stock, 0.00001 P.v. Acquisiton 2021-04-01 12,500 $0.47 148,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, 0.00001 P.v. 27,000 Indirect Held by spouse
Common Stock, 0.00001 P.v. 27,000 Indirect Held by spouse
Footnotes
  1. Note: Acquired on TSX-V Exchange at C$0.50 and C$0.5888 per share